UPC Analytics
DEEN
Übersicht · Eingereicht:

ORD_22245/2025

NOVEL ANTITUMORAL USE OF CABAZITAXEL

Prozessuale & UnteranträgeVerfahrensführungsanordnungenMunich LDGeneric Order
  • 2025-07-17Nur prozessualproceduralGeneric Order

    The Munich Local Division issued a scheduling order following the interim conference in the Sanofi v. Accord/STADA/Reddy/Zentiva infringement actions, setting out next procedural steps pending the written reasoning from the EPO Board of Appeal decision on the relevant patent.